CN Patent

CN107898764A — 一种埃格列净组合物

Assigned to Weihai Guanbiao Information Technology Co Ltd · Expires 2018-04-13 · 8y expired

What this patent protects

本发明涉及一种埃格列净片剂组合物，属于药物制剂技术领域。本发明所述单位剂量埃格列净组合物中，含有D 90 为90‑150微米的埃格列净5‑15mg，乳糖50‑80mg，壳聚糖6‑12mg，十二烷基硫酸钠0.8‑1.5mg，β环糊精6‑10mg，柠檬酸钠12‑20mg，气相二氧化硅8‑15mg，聚维酮K30 4‑8mg，交联聚维酮4‑8mg，硬脂酸镁1‑1.5mg。本发明提供了一种稳定的埃格列净片组合物。

USPTO Abstract

本发明涉及一种埃格列净片剂组合物，属于药物制剂技术领域。本发明所述单位剂量埃格列净组合物中，含有D 90 为90‑150微米的埃格列净5‑15mg，乳糖50‑80mg，壳聚糖6‑12mg，十二烷基硫酸钠0.8‑1.5mg，β环糊精6‑10mg，柠檬酸钠12‑20mg，气相二氧化硅8‑15mg，聚维酮K30 4‑8mg，交联聚维酮4‑8mg，硬脂酸镁1‑1.5mg。本发明提供了一种稳定的埃格列净片组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN107898764A
Jurisdiction
CN
Classification
—
Expires
2018-04-13
Drug substance claim
No
Drug product claim
No
Assignee
Weihai Guanbiao Information Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.